Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE

Pharmaceutical Research

Volumn 19, Issue 6, 2002, Pages 780-786

  Tang, Fuxing ^a   Borchardt, Ronald T ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

Author keywords

Acyolxyalkoxy based cyclic prodrug; Caco 2 cell monolayer; DADLE; MDR 1; MRP 2

Indexed keywords

CYCLOSPORIN A; ELACRIDAR; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; OPIATE PEPTIDE; PRODRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG PENETRATION; DRUG TRANSPORT; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE MUCOSA; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CACO-2 CELLS; CELL LINE; DOGS; ENKEPHALIN, LEUCINE-2-ALANINE; GENES, MDR; HUMANS; INTESTINAL MUCOSA; MITOCHONDRIAL PROTEINS; OPIOID PEPTIDES; P-GLYCOPROTEIN; PERMEABILITY; PRODRUGS; RIBOSOMAL PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0036291816     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016144530146     Document Type: Article

References (37)

1. Delivery of peptides and proteins through the blood-brain barrier
2. Pharmacological characterization of the dermorphin analog
3. Delivery systems for penetration enhancement of peptide and protein drugs: Design considerations
4. Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies
5. Peptide drug delivery into the central nervous system
6. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics
7. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor
8. Active secretion and enterocytic drug metabolism barriers to drug absorption
9. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of a phenylpropionic acid promoiety in a model hexapeptide
10. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of an acyloxyalkoxy promoiety in a model hexapeptide
11. Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability
12. The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide
13. Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using an (acyloxy)alkoxy linker
14. Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: Evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers
15. Caco-2 monolayers in experimental and theoretical predictions of drug transport
16. The application of cell culture systems in drug discovery and development
17. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development
18. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
19. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators
20. The multidrug resistance protein family
21. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
22. Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?
23. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat
24. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum
25. Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF-B
26. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
27. Multidrug resistance and the role of P-glycoprotein knockout mice
28. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
29. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport
30. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
31. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
32. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
33. The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier
34. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening
35. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1